CN108065389A - A kind of double ginseng compound health-care food of Cassia - Google Patents
A kind of double ginseng compound health-care food of Cassia Download PDFInfo
- Publication number
- CN108065389A CN108065389A CN201611003944.XA CN201611003944A CN108065389A CN 108065389 A CN108065389 A CN 108065389A CN 201611003944 A CN201611003944 A CN 201611003944A CN 108065389 A CN108065389 A CN 108065389A
- Authority
- CN
- China
- Prior art keywords
- cassia
- parts
- lotus leaf
- care food
- purple perilla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 26
- 244000037364 Cinnamomum aromaticum Species 0.000 title claims abstract description 19
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 title claims abstract description 19
- 235000013305 food Nutrition 0.000 title claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 9
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 9
- 150000001875 compounds Chemical class 0.000 title claims abstract description 8
- 241000208340 Araliaceae Species 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 28
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 25
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 19
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 19
- 229940082787 spirulina Drugs 0.000 claims abstract description 19
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 18
- 235000004347 Perilla Nutrition 0.000 claims abstract description 17
- 244000124853 Perilla frutescens Species 0.000 claims abstract 3
- 239000000463 material Substances 0.000 claims description 4
- 235000001497 healthy food Nutrition 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 16
- 239000000203 mixture Substances 0.000 abstract description 10
- 229920002472 Starch Polymers 0.000 abstract description 7
- 239000008107 starch Substances 0.000 abstract description 7
- 235000019698 starch Nutrition 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 241000229722 Perilla <angiosperm> Species 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000002386 leaching Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 238000004887 air purification Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014190 Phosphatidylcholine-sterol O-acyltransferase Human genes 0.000 description 1
- 108010011964 Phosphatidylcholine-sterol O-acyltransferase Proteins 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of double ginseng compound health-care food of Cassia, belong to field of health care food.Its raw material includes cassia seed, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb, spirulina powder composition, and powder processed is extracted through cassia seed, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb raw material, prepared by spirulina powder, starch mixture, allotment and etc. it is obtained.Product made from the technique not only takes safety, has significant auxiliary lipid-lowering efficacy, and industrial production cost is low.
Description
Technical field
The present invention relates to a kind of double ginseng compound health-care food of Cassia, belong to field of health care food.
Background technology
Investigation display, China >=18 year old lipid disorders in residents illness rate are 18.6%, and patient is up to 1.6 hundred million.18—44
The dyslipidemia illness rate of year, 45-59 years old and 60 years old crowd are respectively 17%, 22.9% and 23.4%.It can be seen that hyperlipidemia has become
For in, common complaint among the elderly, and the various cardiovascular and cerebrovascular diseases thus triggered become threaten in, the elderly's life it is main
Chief culprit.So health food of the invention with auxiliary reducing blood lipid is the needs of human health, the Gospel for the person that is Hyperlipidemia.
The present invention is directed to the crowd of Hyperlipidemia, and based on tcm health preserving theory, with reference to modern medical theory, selection is determined
Pine torch, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb, spirulina powder are raw material prescription, have the healthcare function of auxiliary reducing blood lipid.Fang Zhong
Cassia seed have and adjust blood fat and adjust blood pressure effect, lotus leaf, purple perilla, Chinese Ladiestresses Root or Herb have promoting blood circulation, reduction blood to glue in side
Stagnant degree improves microcirculation, scavenging activated oxygen, reduces the functions such as lipid peroxide contents.American ginseng conidia powder contains three in side
Terpene can block absorption of the gastro-intestinal tract to cholesterol, and can inhibit the activity of cholesterol synthase, therefore have drop serum
The effect of cholesterol.Spirulina powder hinders the absorption of fat in alimentary canal, and discharges it in vitro, in addition, spirulina powder exists
It is easy to combine with cholic acid in enteron aisle, cholesterol is made to lose conversion and then absorbed condition, and be excreted.To sum up, certainly
Pine torch, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb, spirulina powder are respectively by different mechanism of action and approach, from multi-level, more targets
Point, which intervene, achievees the purpose that reducing blood lipid, and collaboration plays the function of auxiliary reducing blood lipid.
The content of the invention
The invention aims to provide a kind of Cassia double ginseng compound health-care food.Product made from the technique is not only eaten
Safety has significant auxiliary lipid-lowering efficacy, and industrial production cost is low, there is good market development prospect.
To achieve the above object, the present invention adopts the following technical scheme that：
A kind of double ginseng compound health-care food of Cassia, raw material are included by mass fraction：33-35 parts of cassia seed, lotus leaf 12-14
Part, 9-11 parts of purple perilla, 9-11 parts of American ginseng, 12-14 parts of Chinese Ladiestresses Root or Herb, 19-21 parts of spirulina powder.
Preferably, the raw material of the health food is included by mass fraction：34 parts of cassia seed, 13 parts of lotus leaf, purple perilla 10
Part, 10 parts of American ginseng, 13 parts of Chinese Ladiestresses Root or Herb, 20 parts of spirulina powder.
The preparation method of the health food of the auxiliary reducing blood lipid, includes the following steps：
（1）Cassia seed, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb raw material extract powder processed
Cassia seed, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb raw material are subjected to rinsing pulverization process, raw materials treated is immersed in 10
In the purified water of times quality 1 it is small when, be heated to 100 DEG C with multi-function extractor, when extraction 3 is small, 100 mesh filter once
Leaching liquor；The purified water of 8 times of quality is added into filter residue, when extraction 2 is small under same extraction temperature, obtains secondary extraction
Liquid；Leaching liquor merging twice is concentrated under reduced pressure, is condensed into thick medicinal extract, relative density 1.25-1.30；It is done again through vacuum
It is dry into dry extract；It is spare into extract powder to cross 80 mesh sieves through crushing for dry extract；
（2）It is prepared by spirulina powder starch mixture
Spirulina powder with the starch of its twice of mass is uniformly mixed, it is spare to cross 80 mesh sieves；
（3）Allotment
By step（1）The extract powder and step of preparation（2）Spirulina powder starch mixture mixing stir evenly, to fill automatically
Glue Nang machines dress glue Nang.
The advantage of the invention is that：
（1）The raw materials for production of the present invention have cassia seed, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb, spirulina powder, are national food
Product Drug Administration ratifies and accreditation has auxiliary lipid-lowering function.
（2）Played in composition of raw materials of the present invention adjust blood fat function factor for plant polyose class, flavonoids, lotus leaf ketone,
Saponin(e and alkaloid etc..Its mechanism of action mainly has the work for 1. improving lipoprotein lipase and lecithin cholesterol acyltransferase
Property, so as to promote lipid catabolism, inhibit its synthesis transhipment and the deposition on arterial wall；2. with cholesterol or its conversion product
Cholic acid is combined or integrated, and so as to inhibit its absorption in the intestine, promotes degradation and excretion；3. promoting blood circulation, reduction blood are viscous
Degree improves microcirculation；4. scavenging activated oxygen reduces lipid peroxide contents etc..
（3）The production Technology of the present invention has reached advanced international level.The technique is easy to operation, it can be achieved that industrial
Change continuous production, therefore production cost is low.
Specific embodiment
Embodiment 1
The composition and mass fraction of Chinese medicine material：34 parts of cassia seed, 13 parts of lotus leaf, 10 parts of purple perilla, 10 parts of American ginseng, disk
Dragon ginseng 13 parts, 20 parts of spirulina powder.
Its preparation method includes the following steps：
（1）Cassia seed, lotus leaf, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb raw material extract powder processed
By raw material proportioning, the lotus leaf selected, purple perilla, American ginseng, Chinese Ladiestresses Root or Herb raw material are examined through quality standard, crushes rinsing
Processing, by raw materials treated be immersed in the purified water of 10 times of quality 1 it is small when, be heated to 100 DEG C with multi-function extractor, leaching
Carry 3 it is small when, 100 mesh filter to obtain a leaching liquor；The purified water of 8 times of quality is added into filter residue, in same extraction temperature
When the lower extraction 2 of degree is small, secondary leaching liquor is obtained；Leaching liquor merging twice is concentrated under reduced pressure, 65 DEG C -75 DEG C of temperature, pressure
0.06-0.08 MPa when the time 3-4 is small, is condensed into thick medicinal extract, relative density 1.25-1.30；Again through vacuum
It is dried to dry extract, 65 DEG C-75 DEG C of temperature, when 0.06-0.08 MPa of pressure, time 3-4 are small；Dry extract through crush,
It is spare into extract powder to cross 80 mesh sieves；
（2）It is prepared by spirulina powder, starch mixture
By raw material proportioning, examine the spirulina powder selected through quality standard, be uniformly mixed with the starch of its twice of mass, cross 80
Mesh sieve is spare；
（3）Allotment
In 100,000 grades of air purification workshops by proportioning, step is weighed（1）Cassia seed, lotus leaf, purple perilla, American ginseng, the disk of preparation
Dragon ginseng raw material extract powder, with step（2）Spirulina powder starch mixture mixing stir evenly；
（5）Metering filling capsule, packaging
In 100,000 grades of air purification workshops, above-mentioned compound powder is encapsulated with automatic capsule filler, polishing is bottled, sealing,
Packaging.
（6）Product inspection, storage
Every examine is carried out to finished product according to GMP requirements to measure, meets defined storage.
Embodiment 2
The composition and mass fraction of Chinese medicine material：33 parts of cassia seed, 14 parts of lotus leaf, 9 parts of purple perilla, 11 parts of American ginseng, interwined dragon
Join 14 parts, 19 parts of spirulina powder.
Preparation method is the same as embodiment 1.
Embodiment 3
The composition and mass fraction of Chinese medicine material：35 parts of cassia seed, 12 parts of lotus leaf, 11 parts of purple perilla, 9 parts of American ginseng, interwined dragon
Join 12 parts, 21 parts of spirulina powder.
Preparation method is the same as embodiment 1.
Embodiment 4
Animal experiment and human feeding trial the results show：Serum total cholesterol, triglycerides index are positive, high density lipoprotein level
White cholesterol is not significantly lower than control group, judges that there is auxiliary to reduce serum total cholesterol or auxiliary and reduce glycerine three for given the test agent
Ester acts on.Illustrate that this product has auxiliary lipid-lowering function.
The foregoing is merely presently preferred embodiments of the present invention, all equivalent changes done according to scope of the present invention patent with
Modification should all belong to the covering scope of the present invention.
Claims (1)
1. a kind of double ginseng compound health-care food of Cassia, it is characterised in that：The healthy food material is included by mass fraction：Cassia
Son 33% -35%, lotus leaf 12% -14%, purple perilla 9% -11%, American ginseng 9% -11%, Chinese Ladiestresses Root or Herb 12% -14%, spirulina powder
19%—21% 。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611003944.XA CN108065389A (en) | 2016-11-15 | 2016-11-15 | A kind of double ginseng compound health-care food of Cassia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611003944.XA CN108065389A (en) | 2016-11-15 | 2016-11-15 | A kind of double ginseng compound health-care food of Cassia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108065389A true CN108065389A (en) | 2018-05-25 |
Family
ID=62162722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611003944.XA Withdrawn CN108065389A (en) | 2016-11-15 | 2016-11-15 | A kind of double ginseng compound health-care food of Cassia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108065389A (en) |
-
2016
- 2016-11-15 CN CN201611003944.XA patent/CN108065389A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105079046B (en) | A kind of antitumor soft capsule of full ganoderma lucidum and preparation method thereof | |
| CN103829238B (en) | Health food of a kind of reducing blood lipid and preparation method thereof | |
| CN102246920B (en) | Health-care food capable of assisting in reduction of blood fat and preparation method thereof | |
| CN104288345B (en) | A kind of Chinese medicine composition and preparation method thereof of auxiliary reducing blood lipid | |
| CN1646150A (en) | Novel use of the extract of processed ginseng and saponin isolated therefrom | |
| CN103385315A (en) | Vegetable oil composition with hypolipidemic effect as well as preparation method and application thereof | |
| CN104126801A (en) | Blood fat reducing composition containing sterol | |
| CN102318829B (en) | Compound camellia oil health product with function of blood pressure decreasing, and preparation method thereof | |
| KR100854698B1 (en) | Extraction method of ginseng steamed red dietary fiber and ginseng steamed red dietary fiber extracted by this method | |
| CN109602733A (en) | Improve the composition and the preparation method and application thereof of osteoporosis | |
| CN109662186A (en) | A kind of auxiliary reducing blood lipid pressed candy and preparation method thereof | |
| CN102139066A (en) | Chinese medicinalal soft capsule | |
| CN109395029A (en) | Soft capsule preparation containing various plants extract and preparation method thereof | |
| CN103202471B (en) | Health food for reducing blood fat in auxiliary manner and preparation method of health food | |
| CN108065389A (en) | A kind of double ginseng compound health-care food of Cassia | |
| CN101333241B (en) | Process for extracting dioscin, preparation thereof and use | |
| CN109453267A (en) | Sobering-up composition and the preparation method and application thereof | |
| CN105380253A (en) | Cassia seed-ginkgo leaf compound health food | |
| CN109224029A (en) | Blood-fat reducing composition, preparation containing NMN and the preparation method and application thereof | |
| CN1803182A (en) | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN1258372C (en) | Chinese medicinal composition for treating intestine irritable syndrome and its preparing method | |
| CN102048860B (en) | A kind of soft capsule for nasosinusitis pharmaceutical preparation and preparation method thereof | |
| CN105232802B (en) | Procyanidine composition with blood fat reducing effect and preparation method and application thereof | |
| CN101803650A (en) | Compound gingko health protection tea and preparation method thereof | |
| CN100374121C (en) | Tillering onion extract and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180525 |
|
| WW01 | Invention patent application withdrawn after publication |